Table 1.
Hematological and Biochemical Data of the Healthy Group (n=90), β Thalassemia Carriers (n=138), Mild IDA (n=121), and Severe IDA Patients (n=126)
| Healthy mean (SD) | Thalassemia mean (SD) | Mild IDA mean (SD) | Severe IDA mean (SD) | |
|---|---|---|---|---|
| RBC,1012/L | 4.95 (0.37) | 5.80 (0.53) | 4.81 (0.47) | 4.17 (0.58) |
| Hb, g/L | 151 (9) | 119 (11.3) | 110 (7.5) | 90 (9.1) |
| MCV, fL | 90.9 (2.9) | 64.6 (3.4) | 75.3 (4.8) | 73.2 (6.7) |
| MCH, pg | 30.5 (0.9) | 20.7 (1.1) | 21.5 (1.8) | 21.7 (2.7) |
| MCHC, g/L | 335 (9) | 319 (6.9) | 306 (10) | 296 (14) |
| RDW, % | 13.1 (0.6) | 15.7 (1.0) | 17.7 (2.5) | 17.7 (2.3) |
| Ret, 109/L | 47.8 (14.8) | 77.2 (26.1) | 53.4 (23.6) | 54.9 (27.3) |
| Reticulocyte, % | 0.9 (2.2) | 13.4 (4.7) | 11.1 (4.7) | 13.6 (8) |
| Ret He, pg | 33.7 (1.4) | 22.1 (1.6) | 25.3 (2.9) | 22.3 (3.7) |
| RBC He, pg | 30.9 (1.2) | 21.1 (1.3) | 23.2 (2.1) | 21.5 (3.3) |
| IRF, % | 4.4 (3.3) | 8.7 (5) | 12.9 (5.8) | 16.7 (6.2) |
| %MicroR | 1.1 (0.44) | 38.6 (10.9) | 16.5 (9.3) | 21.6 (13.2) |
| %Hypo‐He | 0.3 (0.16) | 13.2 (9.9) | 12.4 (9.6) | 23.4 (16.5) |
| Iron, µmol/L | 17.1 (2.3) | 18.0 (0.7) | 5.7 (3.7) | 3.9 (1.7) |
| Transf, g/L | 2.46 (0.3) | 2.41 (3.1) | 2.49 (0.6) | 3.19 (0.63) |
| Ferritin, µg/L | 103 (54) | 116 (97) | 17 (22) | 13 (15) |
| Sat, % | 28 (5.9) | 29 (10.9) | 5 (3) | 3 (5.5) |
SD, standard deviation; RBC, red blood cells; Hb, hemoglobin; MCV, mean cell volume; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; RDW, red cell distribution width; Ret, reticulocyte; Ret He, reticulocyte hemoglobin equivalent; RBC He, erythrocyte hemoglobin equivalent; IRF, immature reticulocyte fraction; %MicroR, percentage of microcytic red cells; %Hypo‐He, percentage of hypochromic red cells; Transf, transferrin; Sat, % transferrin saturation.